VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,388,056 | +123.1% | 3,804,833 | +149.6% | 0.05% | +126.1% |
| Q2 2023 | $45,895,047 | +81320.4% | 1,524,246 | -12.5% | 0.02% | -30.3% |
| Q1 2023 | $56,368 | -21.1% | 1,742,452 | -30.1% | 0.03% | -15.4% |
| Q4 2022 | $71,457 | -99.9% | 2,493,255 | -31.3% | 0.04% | -25.0% |
| Q3 2022 | $87,478,000 | +17.1% | 3,626,777 | +32.9% | 0.05% | +13.0% |
| Q2 2022 | $74,711,000 | -31.0% | 2,728,699 | -3.4% | 0.05% | -19.3% |
| Q1 2022 | $108,300,000 | -44.6% | 2,823,994 | -53.7% | 0.06% | -43.0% |
| Q4 2021 | $195,387,000 | +37.6% | 6,100,124 | +26.6% | 0.10% | +17.6% |
| Q3 2021 | $141,973,000 | +6.7% | 4,817,565 | +23.1% | 0.08% | +3.7% |
| Q2 2021 | $133,029,000 | +131.9% | 3,914,900 | +121.7% | 0.08% | +105.0% |
| Q1 2021 | $57,377,000 | +226.6% | 1,765,460 | +262.0% | 0.04% | +207.7% |
| Q4 2020 | $17,567,000 | -63.0% | 487,700 | -59.8% | 0.01% | -77.6% |
| Q3 2020 | $47,475,000 | -86.0% | 1,212,345 | -86.9% | 0.06% | -87.5% |
| Q2 2020 | $339,274,000 | +141.4% | 9,249,564 | +51.6% | 0.46% | +47.2% |
| Q1 2020 | $140,534,000 | +113.6% | 6,099,551 | +171.4% | 0.32% | +285.4% |
| Q4 2019 | $65,801,000 | -71.6% | 2,247,316 | -74.1% | 0.08% | -77.7% |
| Q3 2019 | $231,903,000 | +95.0% | 8,682,300 | +86.6% | 0.37% | +105.0% |
| Q2 2019 | $118,908,000 | +95.9% | 4,652,115 | +71.8% | 0.18% | +96.7% |
| Q1 2019 | $60,705,000 | +120.8% | 2,707,606 | +107.7% | 0.09% | +111.6% |
| Q4 2018 | $27,497,000 | +889.8% | 1,303,747 | +769.2% | 0.04% | +1333.3% |
| Q3 2018 | $2,778,000 | -2.0% | 150,000 | +18.1% | 0.00% | -25.0% |
| Q2 2018 | $2,834,000 | -98.5% | 127,037 | -98.5% | 0.00% | -98.4% |
| Q1 2018 | $184,310,000 | +847.9% | 8,385,340 | +902.2% | 0.25% | +811.1% |
| Q4 2017 | $19,444,000 | -18.9% | 836,660 | -19.9% | 0.03% | -25.0% |
| Q3 2017 | $23,984,000 | +256.1% | 1,044,585 | +242.4% | 0.04% | +200.0% |
| Q2 2017 | $6,736,000 | +14.4% | 305,060 | +18.2% | 0.01% | +9.1% |
| Q1 2017 | $5,886,000 | -82.1% | 258,037 | -83.6% | 0.01% | -84.1% |
| Q4 2016 | $32,964,000 | +401.7% | 1,575,720 | +533.9% | 0.07% | +527.3% |
| Q3 2016 | $6,571,000 | -51.2% | 248,582 | -48.8% | 0.01% | -63.3% |
| Q2 2016 | $13,459,000 | – | 485,721 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |